Anita Csizmarik

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy

Ulrich Krafft, Csilla Oláh, Henning Reis et al. · Cancers · 2021 · 64 citations · Full text

Comprehensive analysis of serum chromogranin A and neuron‐specific enolase levels in localized and castration‐resistant prostate cancer

Tibor Szarvas, Anita Csizmarik, Tamás Fazekas et al. · British Journal of Urology · 2020 · 33 citations

MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients

Tibor Szarvas, Michèle J. Hoffmann, Csilla Oláh et al. · Diagnostics · 2020 · 24 citations · Full text

Cisplatin Resistance, Tumor Biology, Chemotherapy Resistance +14

Prevalence of APC and PTEN Alterations in Urachal Cancer

Nikolett Nagy, Henning Reis, Boris Hadaschik et al. · Pathology & Oncology Research · 2020 · 17 citations · Full text

Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer

Anita Csizmarik, Boris Hadaschik, Gero Kramer et al. · Urologic Oncology Seminars and Original Investigations · 2021 · 17 citations · Full text

Androgen Receptor, Urology, Oncology +15